Clinical Trials Browser

Breast Neoplasms, Colonic Neoplasms, Lymphoma, Multiple Myeloma, Neoplasms, Radiation Injuries, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Cardiotoxicity

NCT05465031 2025-03-14

Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)

Phase 4 Recruiting

600 enrolled

Breast

Breast Diseases, Breast Neoplasms, Heart Failure, Neoplasms, Second Primary, Cardiotoxicity

NCT06664528 2025-03-04

CV_CANCER

Recruiting

300 enrolled

Neoplasms, Cardiotoxicity

NCT04262830 2025-01-28

CATCH-HF

Recruiting

150 enrolled

Heart Failure, Neoplasms, Cardiotoxicity

NCT03934905 2024-11-20

Protective Effects of the Nutritional Supplement Sulforaphane on Doxorubicin-Associated Cardiac Dysfunction

Phase 1/2 Recruiting

70 enrolled

Cardiotoxicity

NCT05703126 2024-11-05

Clinical and Diagnostic Significance of Endothelial Dysfunction and Myocardial Contractility in Patients With AML

Phase NA Recruiting

100 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Acute, Cardiotoxicity

NCT06622954 2024-10-02

PROTECT-COR

Phase NA Recruiting

32 enrolled

Breast

Breast Neoplasms, Cardiotoxicity

NCT05851053 2024-05-29

BLOC-II

Recruiting

455 enrolled

Breast

Breast Neoplasms, Heart Failure, Ventricular Dysfunction, Cardiotoxicity

NCT06270667 2024-03-22

LYMfit

Phase NA Recruiting

280 enrolled

Lymphoid

Cardiovascular Diseases, Lymphoma, Motor Activity, Cardiotoxicity

NCT06282796 2024-02-28

Early Prediction and Warning for Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy

Recruiting

600 enrolled

Breast

Breast Neoplasms, Cardiotoxicity

NCT06214195 2024-01-19

START

Phase 3 Recruiting

276 enrolled

Cardiotoxicity

NCT05258448 2023-12-06

COLA

Recruiting

100 enrolled

Thoracic

Heart Diseases, Lung Neoplasms, Radiation Injuries, Cardiotoxicity

NCT05921279 2023-07-25

UCARE

Recruiting

100 enrolled

Breast

Breast Neoplasms, Heart Failure, Cardiomyopathies, Neoplasms, Cardiotoxicity

NCT05732051 2023-03-17

NARNIA

Phase 2 Recruiting

60 enrolled

Breast

Breast Neoplasms, Heart Failure, Cardiotoxicity

Clinical Trials

Generation of Heart Muscle Cells From Blood or Skin Cells of Breast Cancer Patients

Cardio-Onco

A Study of Blood Pressure Control During Cancer Treatment

G-COR

CMR-Onko

STOP-MED CTRCD

BREATHS

ML-CardioTox

SCARA-B

BE-FITTER

HO170DLBCL

BRAVE-HEART

HIMALAYAS

EMPACT

Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted

Cardio CAR-T

Cardiac Magnetic Resonance Monitoring of Immune Checkpoint Inhibitor-related Cardiotoxicity

TRUST-ACE

HER2BIC

CARTIER

Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)

CV_CANCER

CATCH-HF

Protective Effects of the Nutritional Supplement Sulforaphane on Doxorubicin-Associated Cardiac Dysfunction

Clinical and Diagnostic Significance of Endothelial Dysfunction and Myocardial Contractility in Patients With AML

PROTECT-COR

BLOC-II

LYMfit

Early Prediction and Warning for Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy

START

COLA

UCARE

NARNIA